Industry › BioTech

Press Releases

EC Healthcare Announces FY2021/22 Annual Results

Jun 23, 2022 13:46 HKT/SGT

エーザイ、東京都文京区による2022年度認知症検診事業において、「のうKNOW」を活用した脳の健康度測定を実施

Jun 23, 2022 12:00 JST

Novotech Receives CRO Leadership Award for Exceeding Customer Expectations

Jun 23, 2022 08:00 HKT/SGT

Novotech 因超出客户期望而获得 CRO 领导奖

Jun 23, 2022 08:00 HKT/SGT

Novotech 因超出客戶期望而獲得 CRO 領導獎

Jun 23, 2022 08:00 HKT/SGT

Eisai Publishes Potential Economic Value of Investigational Lecanemab in Peer-Reviewed Neurology and Therapy Journal

Jun 22, 2022 13:05 HKT/SGT

エーザイ、「レカネマブ」の潜在的な経済価値について査読学術専門誌Neurology and Therapy誌に掲載

Jun 22, 2022 11:00 JST

中国抗体的旗舰产品舒西利单抗SM03的作用机理在美国免疫领域权威期刊the Journal of Immunology上成功发表

Jun 21, 2022 15:40 HKT/SGT

中國抗體的旗艦產品舒西利單抗SM03的作用機理在美國免疫領域權威期刊the Journal of Immunology上成功發表

Jun 21, 2022 15:39 HKT/SGT

The Mechanism of Action of SinoMab's Flagship Product SM03 is Successfully Published in the Journal of Immunology, a Reputable Journal on Immunology in the U.S.

Jun 21, 2022 15:38 HKT/SGT

医思健康订立可持续发展表现挂钩双重贷款开创香港医疗健康市场先河

Jun 21, 2022 13:00 HKT/SGT

醫思健康訂立可持續發展表現掛鈎雙重貸款開創香港醫療健康市場先河

Jun 21, 2022 12:49 HKT/SGT

EC Healthcare Signs Inaugural Dual-Tranche Sustainability-Linked Facility, The First-of-its-Kind in Hong Kong Healthcare Industry

Jun 21, 2022 12:48 HKT/SGT

エーザイ、人事異動ならびに組織改編（2022年6月17日付）を発表

Jun 17, 2022 17:00 JST

노보텍 소속 아시아 태평양 및 미국 지역 임원진, ‘바이오 2022’ 참가

Jun 15, 2022 21:00 HKT/SGT

中国抗体在美国完成SM17 I期临床试验首例健康受试者给药

Jun 15, 2022 13:05 HKT/SGT

中國抗體在美國完成SM17 I期臨床試驗首例健康受試者給藥

Jun 15, 2022 13:04 HKT/SGT

SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.

Jun 15, 2022 13:03 HKT/SGT

Breakthrough Cooperation of Legend Capital's Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM

Jun 15, 2022 12:08 HKT/SGT

SINGAPORE ANNUAL MEETING: DIA and CoRE Gathering Key Healthcare Experts in Neutral Forum to Discuss Regulatory News and Drug Development

Jun 15, 2022 09:30 JST